Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rekovelle vs Gonal-F for ovarian stimulation in Chinese women
NCT06173869Phase 3Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Mar 2024
- Primary completion
- May 2025
- Countries
- 1
01
Overview
A Phase 3 trial of follitropin delta in female infertility, sponsored by Ferring Pharmaceuticals. Started Mar 2024; status: completed.
02
Drugs
follitropin delta
03
Conditions
female infertility
Beyond the preview
Go deeper on NCT06173869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06173869.